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Air leaks often result in alveolar hypoventilation in mechanically ventilated patients with neu-
romuscular disease. The primary objective of this study was to assess the feasibility, efficacy
and tolerance of a ventilator equipped with an automated air-leak compensation system in
a clinical situation. Fourteen neuromuscular patients with nocturnal air leaks during home ven-
tilation were included in a prospective randomised crossover study. A modified VS Ultra venti-
lator was studied during two consecutive nights and patients were randomly ventilated with
and without a leak-compensation system, respectively. Tolerance, minute ventilation, blood
gas values, sleep parameters, and nocturnal oxygen saturation were assessed. Leak compen-
sation significantly increased the mean inspiratory and expiratory tidal volumes (731 312
vs. 1094 432 ml [pZ 0.002] and 329 130 vs. 496 388 ml [pZ 0.006], respectively) and in-
spiratory and expiratory flows (51.7 8.2 vs. 61.8 12.4 l/min [pZ 0.016] and 63.3 26.2 vs.
83.3 37.8 l/min [pZ 0.013], respectively). The system acted by increasing both inspiratory
time (from 1355  230 to 1527  159 ms, pZ 0.038) and inspiratory pressure (from
14.0  2.8 to 18.3  3.4 cm H2O, pZ 0.002). Leak compensation improved arterial PCO2
(6.18  0.9 vs. 5.21  1.0 kPa, pZ 0.004), slow-wave-sleep latency (119  69 vs.
87  35 min, pZ 0.04), and tolerance. Air-leak compensation is feasible and may produce7 107 776; fax: þ33 147 107 783.
pc.aphp.fr (D. Orlikowski).
8 Published by Elsevier Ltd.
174 D. Orlikowski et al.beneficial effects in neuromuscular patients. The automatic air-leak compensation system
tested here should be evaluated in long-term efficacy and tolerance studies and compared
to other ventilation modes capable of compensating for leaks, such as pressure support.
ª 2008 Published by Elsevier Ltd.Introduction
Long-term home ventilation is an established treatment for
neuromuscular patients with respiratory failure, as it
improves clinical symptoms, daytime function, arterial
blood gas values, sleep quality,1 quality of life,2 and sur-
vival.3 No specific recommendations regarding the choice
between volume-cycled and pressure-cycled ventilators
are made in guidelines about positive-pressure ventilation
for patients with chronic respiratory failure.4 Despite
increased interest in the less expensive pressure-cycled
ventilators, volume-targeted ventilators remain widely
used for non-invasive ventilation (NIV) in patients with neu-
romuscular disease.5 Advantages of volume-cycled ventila-
tion may include greater patient comfort and correction of
nocturnal and diurnal hypoventilation.6 In addition,
volume-cycled ventilators deliver a constant volume inde-
pendently from respiratory impedance, and they have bet-
ter alarm capabilities7 compared to pressure-cycled
ventilators. The main drawback of volume-cycled ventila-
tion is that the set volume is not delivered in the event of
air leaks or increased airway resistance.8,9 Pressure-cycled
ventilators are characterised by greater sensitivity of flow
triggering, better patient-ventilator synchronisation, and
an ability to compensate for air leaks.10 However, the use
of pressure-targeted modes in patients with neuromuscular
diseases remains controversial, because the delivered tidal
volume (Vt) varies according to chest-wall compliance and
airway resistance. Leak-compensating capabilities may be
overwhelmed if the ventilator is unable to maintain inspira-
tory and expiratory cycling, stay at the targeted pressure,
and lengthen the insufflation time.7,11 Air leaks may result
in persistent hypercapnia8 and may occur despite adequate
adherence to the prescribed mechanical-ventilation regi-
men. Air leaks are of special concern during REM sleep,12
when muscle hypotonia increases the risk of alveolar hypo-
ventilation in the event of inadequate ventilator assis-
tance. Minimizing air leaks may be among the best ways
to improve the efficiency of assisted ventilation.13 How-
ever, several measures used to avoid leaks are associated
with poor tolerance in dependent patients 8,14,15 and
require frequent arterial blood gas measurements and/or
repeated sleep recordings to achieve optimal ventilation.
We designed a volume-assured pressure-targeted mode to
counterbalance leaks. Volume-assured pressure-targeted
modes combine the advantages of pressure-targeted and
volume-targeted modes.16e18 We modified the algorithm
of the commercial software to render the inspiratory time
and delivered pressure dependent on the patient’s expira-
tory volume, thereby minimizing hypoventilation in the
event of leakage. Here, we report preliminary results
obtained in a clinical situation with this air-leak com-
pensating system in 14 home-ventilated neuromuscular
patients who had nocturnal air leaks.Methods
Patients
We studied patients who had neuromuscular disease re-
quiring home ventilation and who had nocturnal air leaks
identified on the basis of dry mouth or symptoms of
nocturnal hypoventilation (e.g., daytime sleepiness or
morning headaches) and/or persistent hypercapnia >6.0
kPa despite adequate adherence to the ventilation regi-
men. Non-inclusion criteria were unwillingness to provide
consent to participation in the study, age younger than
18 years, respiratory distress, and need for oxygen therapy.Ventilator settings
We used the VS Ultra ventilator (SAIME, Savigny le Temple,
France), which is a home ventilator capable of volume- and
pressure-targeted modes. The VS Ultra ventilator is usually
proposed in a single circuit configuration. An optional
double limb configuration is also available incorporating
an expiratory spirometry. The ventilator was used both in
pressure-controlled mode and in a double-circuit configu-
ration.19 The back-up rate, inspiratory time (Ti), and inspi-
ratory pressure (Ipap) settings were those normally used by
the patient at home. Pressure was set at the usual level of
Ipap if the patient used a pressure-targeted mode at home.
In patients who normally used volume-targeted ventilation,
Ipap was set during the day to achieve the same Vt as with
the home ventilator. Adjustments were made to obtain
a daytime arterial PCO2 equivalent to the PCO2 observed
with the home ventilator. No Epap was prescribed. The trig-
ger was set at 3 (1 being the most and 6 the least sensitive
trigger value).
When the leak-compensation mode is active, the venti-
lator monitors the patient’s expiratory tidal volume (Vte)
cycle by cycle, and an algorithm automatically adjusts the
ventilator parameters to maintain a minimum level of
ventilation. The ventilator continuously calculates the
mean of the previous and current Vte value. A security
volume (Vts) is set based on the home ventilator parame-
ters: Vts is the set Vt if the usual mode is volume-cycled
and the Vt measured by the ventilator if the usual mode is
pressure-cycled. When leaks occur, the ventilator tries to
maintain Vte at Vts or higher. If Vte falls below Vts, the
ventilator automatically increases Ti cycle by cycle, in
steps of þ11%, to lengthen the insufflation while keeping
the pressure constant, to a maximum of þ33% of the initial
Ti (Timax). The ventilator stops the increase procedure at
the Ti that achieves the Vts. When Vts is not achieved at
Timax, the ventilator then automatically increases Ipap cy-
cle by cycle, in steps of þ1 cm H2O, to a maximum of
þ5 cm H2O (Ipapmax). The ventilator stops the increase
Table 1 Respiratory parameters and morning blood gas
values with and without the leak-compensation system.
NZ 14 No compensation Compensation p value
Vti, ml 731 312 1094 432 0.002
Vte, ml 329 130 496 388 0.006
Finspi, l/min 51.7 8.2 61.8 12.4 0.016
Fexpi, L/min 63.3 26.2 83.3 37.8 0.013
Ti, ms 1355 230 1527 159 0.038
Ti/tot 0.40 0.05 0.41 0.04 0.33
RR 17.9 3.4 16 2.6 0.05
Ipap cm H2O 14.0 2.8 18.3 3.4 0.002
pH 7.39 0.04 7.43 0.05 0.003
PaCO2, kPa 6.18 0.9 5.21 1.0 0.004
PaO2, kPa 11.2 2.0 11.3 2.4 0.92
CO2total, mmol/l 29.2 3.5 26.7 3.3 0.064
SaO2% 95.7 2.1 96.0 2.7 0.47
Abbreviations: Vti, inspiratory tidal volume; Vte, expiratory
tidal volume; Finspi, inspiratory flow; Fexpi, expiratory flow; Ti,
inspiratory time; Tot, total duty cycle; RR, respiratory rate;
Ipap, inspiratory pressure.
Air-leak compensation in neuromuscular patients 175procedure at the Ipap value that achieves the Vts. If Vts is
still not achieved, the ventilator functions at Timax and
Ipapmax. If Vts is achieved, the ventilator returns gradually
to the previous settings, as long as Vte remains above Vts.
The leak-compensation procedure starts at the first drop in
Vte. For this study, we developed a counter that recorded
the number of times the air-leak compensation procedure
was started.
Study design
We used a prospective randomised crossover design. The
study was approved by our institutional review board, and
written informed consent was obtained from all patients
prior to study inclusion. After the randomisation procedure,
the patients were studied during two nights. They used
their own interface during both nights. Patients were
unaware of the ventilation modes used during the two
nights.
Measurements
Full polysomnography was performed using the BRAIN-NET
system (Medatec, Brussels, Belgium). Electrophysiological
recordings included three electro-encephalogram channels,
two electro-oculogram channels, a chin electromyogram,
an electrocardiogram (V2 lead), and electromyograms of
the right and left tibialis muscles. Inspiratory and expi-
ratory flows were measured using a pneumotachograph
(Fleisch #2, Lausanne, Switzerland) situated between the
interface and the ventilatory circuit (after the Y piece).
Interface pressure was measured using a differential pres-
sure transducer (Validyne MP 45 100 cm H2O, Northridge,
CA). Abdominal and thoracic movements were recorded
using respiratory inductive plethysmography (Respitrace;
Ambulatory Monitoring, Ardsley, NY). Gas exchanges were
assessed by continuous recording of oxygen saturation
(SpO2) (Ohmeda Biox, BOC Healthcare, Boulder, CO) and
of transcutaneous carbon dioxide tension (PtCO2) (Radi-
ometer TCM3, Copenhagen, Denmark).
Data analysis
Minute ventilation, Vte and Vti, mean inspiratory and
expiratory flow (Finspi and Fexpi), Ti, Ttot, Ipap, and respira-
tory rate (RR) were measured continuously during both
nights. Morning arterial blood gas values were measured
at the end of each night just before disconnection of the
ventilator.
Tolerance was assessed at the end of each night using
a 10-cm visual analogue scale (VAS) on which 0 indicated
very poor tolerance and 10 very good tolerance. At the end
of the study, the patients were asked whether they would
like to use the leak-compensation mode.
Sleep data for all patients were read by the same
operator (GM), who was blinded to the ventilation mode.
Sleep was staged in 30-s periods using Rechtschaffen and
Kales criteria.20 Arousals were evaluated using American
Sleep Disorders Association (ASDA) criteria.21 Time of sleep
onset, total sleep period (TSP, time in minutes from sleep
onset to final wakening), total sleep time (TST, time inminutes spent sleeping during the TSP), sleep efficiency in-
dex (TST/TSP 100), number of arousals, percentage of
TST spent in each sleep stage (stage 1, stage 2, stages 3e4
or slow-wave-sleep, and rapid-eye-movement sleep [REM]),
duration of delta sleep (stages 3 and 4) in minutes, and
REM latency were recorded.
Apnoeas and hypopnoeas were scored using inductive
plethysmography as previously described.22 Minimal and
mean SaO2 were measured, as well as the time in minutes
and percentage of time spent with SaO2< 90%. The differ-
ence in peak PtCO2 between wakefulness and sleep (Delta
PtCO2) was calculated.
Statistical analysis
All data are expressed as mean (SD) values. Respiratory and
sleep parameters with or without leak compensation were
compared using the non-parametric Wilcoxon rank test.
Values of p smaller than 0.05 were considered significant.Results
Patients characteristics
Fourteen patients were randomised. Nocturnal PtCO2 was
recorded in only 10 patients. Mean VC was 1178 493 ml
in the seated position and 1049 484 ml in the supine posi-
tion. Mean Pimax was 40 20 cm H2O and mean Pemax was
40 19 cm H2O. Of the 14 patients, 13 used a ventilator
at home during the night only and one required 24-hour
ventilation. All 14 patients complained of nocturnal leaks
and five patients had persistent hypercapnia during me-
chanical ventilation. Patient characteristics are reported
in Table 1. With the home ventilator, mean VT was
665 142 ml, mean RR was 15.5 2.6 breaths/min, and
mean Ti was 1.25 0.14 s.
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Respiratory and ventilator parameters
Mean set Ipap was 15.5 3.1 cm H2O and mean set Vts was
633 118 ml (Tables 1 and 2). Without leak compensation,
50% of the target Vts was achieved, compared to 74% with
leak compensation (Table 2). Mean percentage of compen-
sated cycles ([number of compensated cycles/number of
effective cycles]  100) was 97.5% (8687/8907 cycles). With
leak compensation, Vti, Ti, Ttot, and Ipap increased signifi-
cantly (Table 2, Fig. 1). Significant increases in Finspi and Fexpi
were noted (Table 2). Mean ventilation timewas similar in the
two study nights (9.1 0.7 vs. 8.9 1.2 h, pZ 0.60).
Arterial blood gas values
Immediately before ventilator disconnection, arterial PCO2
was significantly lower and pH significantly higher with air-
leak compensation (Table 2). No significant effects on alka-
line reserve or PO2 were noted.
Sleep parameters
The VAS scores indicated that tolerance of ventilation was
better with the air-leak compensation system (Table 2). We
found no effects on TST or sleep efficiency. Significant
decreases were noted in slow-wave sleep latency and
non-significant decreases in stage 1 and REM-sleep laten-
cies. No differences in sleep-stage durations were found,
and neither was there any effect on sleep arousal indices
or the incidence of hypopnoea/apnoea. With air-leak com-
pensation, the percentage of time spent with SaO2 <90%
tended to be lower, and there was a non-significant in-
crease in delta PtCO2. At the end of the study, nine (66%)Table 2 Sleep parameters with and without leak
compensation.
NZ 14 No
compensation
Compensation p value
VAS score 6.4 2.0 7.3 1.5 0.02
TST, min 332 87 318 99 0.55
Sleep efficiency, % 76.3 13.2 73.6 15.7 0.49
Stage 1 sleep
latency, min
66 48 45 32 0.22
Stages 3, 4 sleep
latency, min
119 69 87 35 0.04
REM sleep
latency, min
188 114 184 111 0.38
Arousal/marousal
index, n/h
20.1 13.2 22.1 19.6 0.67
Apnoea/hypopnoea
index, n/h
7.5 13.0 5.7 6.5 0.33
Mean SaO2% 93.8 2.6 94.4 2.0 0.17
Minimal SaO2% 86.4 6.6 87.0 3.9 0.33
% Time SaO2 <90% 7.4 17.4 5.1 10.7 0.14
Delta PtCO2 (mmHg) 3.52 6.85 0.54 12.7 0.86
Abbreviations: VAS, visual analogue scale; TST, total sleep time;
REM, rapid-eye-movement sleep; marousal, micro-arousal; SaO2,
oxygen saturation; PtCO2, transcutaneous PCO2.
Figure 1 Changes in inspiratory tidal volume (a), expiratory
tidal volume (b) and inspiratory pressure (c) with (black line)
and without (grey line) leak compensation in patient 14.patients stated that they would like to use the air-leak
compensation system at home.
Discussion
In this short-term study conducted in home-ventilated
neuromuscular patients who complained of nocturnal air
leaks, an automated air-leak compensation system im-
proved minute ventilation, blood gas values, and sleep
parameters.
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ventilation in patients with chronic or acute respiratory
failure.13 In home-ventilated patients, leaks can occur
during invasive or non-invasive ventilation. Air leaks are
particularly common around nasal masks but occur also
with other interfaces such as oronasal masks and uncuffed
tracheostomy tubes.8,23 Air leaks during the day was
reported to decrease the effective Vt by up to 34%; leak
severity correlated to PCO2, and the most common cause
of leakage was an inadequate seal between the interface
and the patient.8 During sleep, Vt reduction due to air
leaks may have severe adverse effects in neuromuscular
patients.24,25 Reduced ventilatory assistance in patients
with muscle weakness results in patient discomfort,
decreases the effectiveness of ventilation, and disrupts
patient-ventilato synchronisation and sleep architecture,8,26
even in the absence of diurnal hypercapnia.27
Several strategies have been used to reduce leaks. When
leaks occur around a nasal mask, switching to an oronasal
mask,28 using a chinstrap,8 or taping the mouth25 may
reduce leakage by improving the seal between the patient
and the interface. However, these techniques are often dif-
ficult to implement and poorly tolerated by patients with
advanced neuromuscular disease, who have severe muscle
weakness, respiratory failure, swallowing disorders, and dif-
ficulty clearing the airway.14 A tightly applied mask may
cause pressure sores. In tracheostomised patients, using
a cuffed tube may reduce leaks but also limits phonation
and carries a risk of tracheal lesions in the long term.8,14
In addition, in the event of ventilator failure, the dependent
patient is unable to remove an oronasal mask in order to call
for help.24 Furthermore, methods designed to improve the
patient-interface seal are not effective in all patients.8 An-
other strategy, which is used empirically, consists in increas-
ing Vt during volume-targeted ventilation, or pressure
during pressure-targeted ventilation, in order to increase
Vti. This strategy is usually well tolerated and efficient
with volume-targeted ventilation8 but increases upper air-
way pressure during leak-free periods with pressure-
targeted ventilation.29,30 Although these methods can
reduce the risk of hypoventilation, they fail to eliminate
other leak-related complications, such as upper airway
dryness, nasal obstruction, and ineffective triggering.31 On
the other hand, we could have used a commercial volume-
assured-pressure support, in this study, to achieve a suffi-
cient minute ventilation in case of leaks. These devices
increase the Vti especially when working with in a single
circuit configuration without monitoring of the expiratory
volume. It may expose to inefficient compensation espe-
cially when inspiratory leaks are present.
It has been suggested that leaks may induce arousal.
However, despite an increase in absolute leak size, we
found that increasing air leaks via the compensation system
failed to induce arousal. Our air-leak compensation system
was well tolerated, although our patients were severely
disabled and dependent.
Few studies have sought to determine the optimal mode
of ventilation in neuromuscular patients. Pressure- and
volume-targeted modes seem to have similar effects on
alveolar hypoventilation.32 Home ventilators vary markedly
regarding their ability to compensate for air leaks. Pres-
sure-targeted ventilators have better compensationcapabilities than do volume-targeted ventilators, and Vt
delivered during leakage is best maintained by pressure-
targeted modes. Effectiveness in compensating for air leaks
depends on the ability of the ventilator to reach and to
maintain a sufficient inspiratory flow rate, and large leaks
often overwhelm compensation capabilities.11 Pressure
support33 compensates for air leaks by increasing Ti, often
without appropriate adjustment of inspiration duration,
which may lead to excessive insufflation time and to inver-
sion of the inspiration/expiration ratio.11 We used pressure-
targeted ventilation in our study to obtain optimal control
of both Ipap and Ti and to determine which of these adjust-
ments was most effective for leak compensation. The stud-
ies were done with zero end-expiratory pressure, because
the system may overestimate leaks when positive end-
expiratory pressure is present; in addition, neuromuscular
patients usually have very low levels of intrinsic positive
end-expiratory pressure.34 Our leak-compensation mode
shares similarities with pressure-augmentation modes.35 It
more closely resembles volume-targeted ventilation17
than volume-assured or average-volume-assured pressure-
support modes, which combine the benefits of pressure-
and volume-targeted ventilation. These modes were first
used for brief periods in patients who had acute respiratory
failure16 or were undergoing weaning.33 Recently, they
were used for the long-term treatment of obesity-related
hypoventilation syndrome.18 In these studies, the goal
was to adjust for acute changes in ventilatory demand or
to improve work of breathing in patients with acute unsta-
ble respiratory failure.17 In our study, in contrast, the goal
was to counterbalance the effects of air leaks in patients
with chronic stable respiratory failure. Our air-leak com-
pensation system also shares similarities with expert-based
knowledge modes, which have been used to automatically
assist in weaning by allowing a minimal acceptable level
of pressure36 or, more recently, to maintain alveolar venti-
lation in patients with acute respiratory failure.37 The orig-
inal feature of our leak compensation mode is that a Ti
increase is combined with an Ipap increase to maintain suf-
ficient minute ventilation based on monitoring of the pa-
tient’s Vte. The ventilator takes the amount of leakage
into account, cycle by cycle, and increases Vti to obtain
a Vte value as close as possible to the set Vts. When the
leak compensation program is activated, Vti is increased,
first by increasing Ti (by up to 33% if needed) then by in-
creasing Ipap. Significant Ti and Ipap increases occurred
in our study, indicating that both adjustments were effec-
tive in compensating for leaks and maintaining Vts. Surpris-
ingly, the Ti increase was smaller than expected (13% on
average). Thus, the ventilator stopped the Ti increase pro-
cedure before the maximal set limit of þ33%, thereby lim-
iting the risk, in clinical situation, of inspiration/expiration
inversion and autocycling, by maintaining the Ti/Ttot ratio
below 0.5.11,31 One important limitation of our system is
that expiratory leaks may lead to errors by decreasing
the Vte detected by the ventilator.18 The result may be
inappropriately large increases in Ti, inspiratory flow, and
Ipap, possibly producing lung overinflation. Excessive pres-
sure level increases due to the leak-compensation system
may also increase the size of the leaks and worsen dynamic
hyperinflation, as reported in patients with obstructive lung
disease.38 The impact of such hyperinflation is probably
178 D. Orlikowski et al.more limited in neuromuscular patients. Furthermore, we
limited the Ipap increase to a maximum of þ5 cm H2O,
which probably helped to limit leak increases and drops in
mask occlusion pressure, as well as to avoid cycling-off fail-
ure39 and barotrauma. However, the limitations placed on
the Ti and Ipap increases for safety reasons also limited
the leak-compensation capabilities of the system. There-
fore, in the event of large leaks, compensation was only
partial, which restricted the ability of the system to more
improved sleep and respiratory parameters.Conclusion
We studied a dual-control mode that targeted a Vte value,
in order to compensate for nocturnal air leaks in patients
with neuromuscular disease. This mode improved minute
ventilation, blood gas values, and several sleep parame-
ters. It was well tolerated despite the presence of severe
neuromuscular disease in our patients. It was effective with
both invasive and non-invasive ventilation in our short-
term study. Our leak-compensation system is probably
less effective in compensating for expiratory leaks than
inspiratory leaks and may be ineffective when the entire
Vte leaks around the interface. Nevertheless, our results
support the feasibility of air-leak compensation and suggest
beneficial effects in neuromuscular patients. Our leak-
compensation system deserves to be assessed in long-
term studies of efficacy and tolerance comparatively to
other modes of ventilation capable of leak compensation,
such as pressure-support ventilation.Acknowledgement
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